Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026, at 9:20 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-TechneBio?Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota,?celebrating 50 years of empowering scientific?and?diagnostic?communities?to reach?better answers. The company provides high?quality reagents, analytical instruments,?and?precision diagnostics.?Its portfolio is organized into three customer?focused brands:?R&D Systems(TM), Bio?Techne Spatial(TM), and Bio?Techne?Diagnostics(TM), reflecting?the scientific journey from discovery to?translational?research?to clinical decision?making.?Bio?Techne operates?in?34 locations worldwide and employs approximately 3,100 people. In fiscal year 2025, the company generated over?$1.2 billion?in net sales.?Its more?than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.
For more information on Bio-Techne and its brands, please visit?www.bio-techne.com?or follow the company on social media at?LinkedIn,?X,?or?YouTube.
 |
Contact: David Clair, Vice President, Investor
Relations
david.clair@bio-techne.com
|  |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference-302760526.html
SOURCE Bio-Techne Corporation
https://rt.newswire.ca/rt.gif?NewsItemId=CG49480&Transmission_Id=202605040700PR_NEWS_USPR_____CG49480&DateId=20260504
COMTEX_478495319/1005/2026-05-04T06:59:55 |